PureTech Health plc – Half-Year Report
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Bristol-Myers Squibb Co. (BMY) PT Raised to $51 at Jefferies
August 28, 2024 5:41 AM EDTJefferies analyst Akash Tewari raised the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $51.00 (from $49.00) while maintaining a Hold rating.
The analyst comments "Bayer will present asundexian OCEANIC-AF data at ESC (stopped due to inferior efficacy vs Eliquis). While we remain on... More
